Study to Evaluate the Safety and Efficacy of the Cytrellis Micro-Coring Device for the Treatment of Moderate to Severe Facial Wrinkles

ConditionWrinkle
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-70
SponsorCytrellis Biosystems, Inc.

About this trial

Study evaluating the efficacy of a micro coring device for the treatment of moderate to severe check wrinkles

Eligibility criteria

Qualifiers

Males and females 40-70 years of age

Fitzpatrick Skin Type I to IV as judged by the Investigator

Cheek areas are at least a score of 3 using the Lemperle Wrinkle Assessment Scale as judged by the Investigator

Able to provide written informed consent, understand and willing to comply with all study related procedures and follow-up visits.

Disqualifiers

Lesions suspicious for any malignancy or the presence of actinic keratosis, melasma, vitiligo, cutaneous papules/nodules or active inflammatory lesions in the areas to be treated

History of keloid formation or hypertrophic scarring

History of trauma or surgery to the treatment areas in the past 6 months

Scar present in the areas to be treated

Trial design

Treatments tested in this trial

  • MCD

Treatment groups

35 Participants
are divided into 1 treatment group

Sponsors and collaborators